Want to see CTVA full AI Analyst Report?
CTVA Stock Chart & Stats
$83.05
$0.47(0.53%)
At close: 4:00 PM EDT
$83.05
$0.47(0.53%)
Day’s Range― - ―
52-Week Range$60.54 - $90.97
Previous CloseN/A
Volume2.48M
Average Volume (3M)3.89M
Market Cap
$55.25B
Enterprise Value$59.23K
Total Cash (Recent Filing)$2.37B
Total Debt (Recent Filing)$4.88B
Price to Earnings (P/E)54.8
Beta0.40
Next Earnings
Nov 11, 2026EPS Estimate
-0.39Next Dividend Ex-DateN/A
Dividend Yield0.87%
Share Statistics
EPS (TTM)1.51
Shares Outstanding667,196,000
10 Day Avg. Volume3,143,736
30 Day Avg. Volume3,887,893
Financial Highlights & Ratios
PEG Ratio1.89
Price to Book (P/B)1.89
Price to Sales (P/S)2.62
P/FCF Ratio16.19
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$93.93Price Target Upside13.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)3.75
Revenue Forecast (FY)$18.12B
Bulls Say, Bears Say
Bulls Say
Raised Guidance And ExecutionHigher full-year guidance, strong first-half growth and nearly 200 basis points of margin expansion indicate improved execution. Productivity savings and commercial momentum could support earnings durability beyond a single quarter.
Innovation And Licensing StrengthA differentiated pipeline of seeds, traits and crop-protection products supports pricing, mix and market relevance. Licensing momentum also monetizes Corteva’s technology base and can provide scalable, less asset-intensive growth.
Conservative Balance SheetLow leverage and a stable equity base provide financial flexibility to fund research, seasonal working capital and strategic separation needs. This capitalization also improves resilience if agricultural demand or pricing weakens.
Bears Say
Weakening Revenue And Cash FlowThe latest deterioration in revenue and free cash flow signals weaker operating momentum and higher cash-flow volatility. Even if some decline reflects timing or one-time items, sustained weakness could constrain investment and capital returns.
Crop-protection Pricing PressurePersistent pricing pressure, particularly in Brazil, can offset volume growth from new products and compress segment margins. Generics and competitive markets may limit Corteva’s ability to recover input costs or sustain prior profitability.
Separation Financing ComplexityThe planned separation introduces financing, execution and allocation complexity, with the standalone seed business carrying substantial borrowings for working capital and strategic needs. This could increase interest costs and reduce flexibility during downturns.
Corteva News
CTVA FAQ
What was Corteva’s price range in the past 12 months?
Corteva lowest stock price was $60.53 and its highest was $90.97 in the past 12 months.
What is Corteva’s market cap?
Corteva’s market cap is $55.25B.
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is Nov 11, 2026 which is in 77 days.
How were Corteva’s earnings last quarter?
Corteva released its earnings results on Jul 30, 2026. The company reported $2.3 earnings per share for the quarter, beating the consensus estimate of $2.236 by $0.064.
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva pays a Quarterly dividend of $0.18 which represents an annual dividend yield of 0.87%. See more information on Corteva dividends here
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is -0.39.
How many shares outstanding does Corteva have?
Corteva has 667,196,000 shares outstanding.
What happened to Corteva’s price movement after its last earnings report?
Corteva reported an EPS of $2.3 in its last earnings report, beating expectations of $2.236. Following the earnings report the stock price went down -11.898%.
Which hedge fund is a major shareholder of Corteva?
Currently, no hedge funds are holding shares in CTVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Corteva Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$93.93 (13.10% Upside)
$93.93 (13.10% Upside)
Blogger Sentiment
Bullish
CTVA Sentiment 63%
Sector Average 62%
Sector Average 62%
Hedge Fund Trend
Increased
By 179.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 0.7%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
23.24%
12-Months-Change
Fundamentals
Return on Equity
0.87%
Trailing 12-Months
Asset Growth
-0.28%
Trailing 12-Months
Company Description
Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
CTVA Company Deck
CTVA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call delivered a broadly positive message: strong first-half execution drove revenue, margin and EBITDA gains; management raised full-year guidance and reported meaningful progress on the planned separation with dis-synergies largely mitigated. Notable challenges include crop protection pricing pressure (especially in Brazil), near-term cash flow impacts from one-time items, seasonal Q3 weakness and farmer margin/credit constraints in Latin America. Overall the company emphasized durable technology-led demand, productivity gains, and a healthy new product and licensing pipeline, while acknowledging localized and timing risks.View all CTVA earnings summariesCTVA Revenue Breakdown
40.24% Corn
10.79% Soybean
3.70% Other oilseeds
2.15% Other
21.44% Herbicides
9.59% Insecticides
6.55% Fungicides
2.98% Biologicals
2.56% Other
CTVA Stock 12 Month Forecast
Average Price Target
$93.93
▲(13.10% Upside)
Technical Analysis
Ownership Overview
0.16% Insiders
30.80% Mutual Funds
21.35% Other Institutional Investors
22.42% Public Companies and
Individual Investors